title: Efficacy of icatibant treatment in patients with hereditary angio-oedema type I resistant to treatment with C1 inhibitor concentrate.
authors.forename: L
authors.initials: L
authors.lastname: Bouillet
authors.forename: I
authors.initials: I
authors.lastname: Boccon-Gibod
authors.forename: C
authors.initials: C
authors.lastname: Dumestre-Perard
authors.forename: J Y
authors.initials: JY
authors.lastname: Cesbron
authors.forename: C
authors.initials: C
authors.lastname: Massot
mesh_terms: D000293:Adolescent; D000328:Adult; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D065168:Bradykinin Receptor Antagonists; D050718:Complement C1 Inhibitor Protein / Q000627:therapeutic use*; D004351:Drug Resistance; D004361:Drug Tolerance; D005260:Female; D056829:Hereditary Angioedema Types I and II / Q000188:drug therapy*; D006801:Humans
chemical_list: D065168:Bradykinin Receptor Antagonists; D050718:Complement C1 Inhibitor Protein; C065679:icatibant; D001920:Bradykinin